These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18721112)

  • 1. Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions.
    Lewis DF; Ito Y
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1181-6. PubMed ID: 18721112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions.
    Lewis DF
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):5-8. PubMed ID: 16922648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into understudied human cytochrome P450 enzymes.
    Machalz D; Pach S; Bermudez M; Bureik M; Wolber G
    Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling human cytochromes P450 for evaluating drug metabolism: an update.
    Lewis DF
    Drug Metabol Drug Interact; 2000; 16(4):307-24. PubMed ID: 11201309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
    Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 57 varieties: the human cytochromes P450.
    Lewis DF
    Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.
    Skopalík J; Anzenbacher P; Otyepka M
    J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.
    Maréchal JD; Kemp CA; Roberts GC; Paine MJ; Wolf CR; Sutcliffe MJ
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S82-9. PubMed ID: 18026129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B; Chow D; Hu M
    Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
    Strolin Benedetti M; Whomsley R; Baltes E
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):895-921. PubMed ID: 17125408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
    Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
    J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
    Lewis DF; Ito Y
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.
    Ong CE; Pan Y; Mak JW; Ismail R
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1097-113. PubMed ID: 23682848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.